Hidradenitis suppurativa/acne inversa. An update

被引：23

作者：

Kirschke, J. ^{[1
]}

Hessam, S. ^{[2
]}

Bechara, F. G. ^{[2
]}

机构：

[1] HELIOS St Elisabeth Klin Oberhausen, Klin Dermatol Venerol & Allergol, Oberhausen, Germany

[2] Klin Ruhr Univ Bochum, St Josef Hosp, Abt Dermatochirurg, Klin Dermatol Venerol & Allergol, D-44791 Bochum, Germany

来源：

HAUTARZT | 2015年 / 66卷 / 06期

关键词：

Inflammatory disease; Treatment outcome; Therapy; Diagnosis; Excision; SQUAMOUS-CELL CARCINOMA; CONTROLLED CROSSOVER TRIAL; LABEL CLINICAL-TRIAL; ACNE INVERSA; GAMMA-SECRETASE; DOUBLE-BLIND; TNF-ALPHA; CHROMOSOME; 1P21.1-1Q25.3; CYPROTERONE-ACETATE; SURGICAL-TREATMENT;

D O I：

10.1007/s00105-015-3616-y

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Hidradenitis suppurativa/acne inversa (HS/AI) is a chronic inflammatory disease characterized by painful nodules, abscesses, fistulas, sinus tracts and scarring, which may lead to severe functional and psychological impairment. Patients often suffer for many years before the right diagnosis is finally made. HS/AI is still a therapeutic challenge. Conservative therapies play a role in mild stages of the disease; however they do not result in healing. Therapy of choice associated with the lowest recurrence rate is a radical wide excision of involved skin.

引用

页码：413 / 422

页数：10